Ben Lewis and Christina Lopes just finalized a series A for their company, One Health, which is working to improve medical treatments for dogs — in ways that could improve cancer care in humans as well.
Lilly announced additional findings indicating that its rheumatoid arthritis drug, baricitinib, may improve the health of severe Covid-19 patients when used in combination with Gilead Science’s antiviral drug remdesivir.
Flagship Pioneering’s David Berry founded Valo Health 18 months ago with an eye to making an AI platform to develop drugs more quickly and efficiently.
The pharmaceutical company said its drug baricitinib, combined with remdesivir, reduces median hospital stays by one day compared to remdesivir alone, and is pursuing an emergency use authorization with the FDA.
David Baker, whose protein design technology is being used to develop therapies for Covid-19 and cancer, received one of several awards to scientists from the Breakthrough Prize Foundation that add up to a combined total of $21.75 million.
Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”
Biotech company Mammoth Biosciences has signed an exclusive deal with University of California Berkeley to license a newly-discovered class of Crispr proteins.
This group of Silicon Valley veterans have joined forces with an environmental scientist to bring hospital grade UV-C disinfection to schools and to businesses like hotels and restaurants.